Gene · 6500
Papers4,444
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,444
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner. | Signal Transduct Target Ther | 2023 | 36765030 | PubTator, text mining | PubMed |
| Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancer. | JCI Insight | 2023 | 36757813 | PubTator, text mining | PubMed |
| Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer. | Heliyon | 2023 | 36747547 | PubTator, text mining | PubMed |
| Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | Mol Cell | 2023 | 36736316 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy. | Front Immunol | 2023 | 36733484 | PubTator, text mining | PubMed |
| 14-3-3 proteins regulate cullin 7-mediated Eag1 degradation. | Cell Biosci | 2023 | 36717938 | PubTator, text mining | PubMed |
| Anthocyanin metabolism in Nelumbo: translational and post-translational regulation control transcription. | BMC Plant Biol | 2023 | 36710356 | PubTator, text mining | PubMed |
| Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma. | Nat Commun | 2023 | 36707509 | PubTator, text mining | PubMed |
| SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma. | Mol Cells | 2023 | 36694914 | PubTator, text mining | PubMed |
| Protein degradation: expanding the toolbox to restrain cancer drug resistance. | J Hematol Oncol | 2023 | 36694209 | PubTator, text mining | PubMed |
| Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation. | Mol Cell | 2023 | 36693379 | PubTator, text mining | PubMed |
| Loss of the E3 ubiquitin ligases UBR-5 or HECD-1 restores Caenorhabditis elegans development in the absence of SWI/SNF function. | Proc Natl Acad Sci U S A | 2023 | 36689659 | PubTator, text mining | PubMed |
| The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment. | Int J Mol Sci | 2023 | 36674480 | PubTator, text mining | PubMed |
| E3 Ubiquitin Ligase TRIP12 Controls Exit from Mitosis via Positive Regulation of MCL-1 in Response to Taxol. | Cancers (Basel) | 2023 | 36672454 | PubTator, text mining | PubMed |
| PDE6D Mediates Trafficking of Prenylated Proteins NIM1K and UBL3 to Primary Cilia. | Cells | 2023 | 36672247 | PubTator, text mining | PubMed |
| Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications. | Antioxidants (Basel) | 2023 | 36670985 | PubTator, text mining | PubMed |
| Palmitoylation and PDE6δ regulate membrane-compartment-specific substrate ubiquitylation and degradation. | Cell Rep | 2023 | 36662618 | PubTator, text mining | PubMed |
| Reciprocal REGγ-Nrf2 Regulation Promotes Long Period ROS Scavenging in Oxidative Stress-Induced Cell Aging. | Oxid Med Cell Longev | 2023 | 36659906 | PubTator, text mining | PubMed |
| Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target. | Clin Transl Med | 2023 | 36650113 | PubTator, text mining | PubMed |
| Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. | Signal Transduct Target Ther | 2023 | 36646695 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6500/papers?page=25